Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Appointed director
Phio Pharmaceuticals Corp. (RXII) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/29/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
11/04/2019 3 Ferrara Robert L (Director) has filed a Form 3 on Phio Pharmaceuticals Corp.
04/24/2019 3 Barrett John A (Chief Development Officer) has filed a Form 3 on Phio Pharmaceuticals Corp.
06/07/2017 3 Freeman Jonathan E (Director) has filed a Form 3 on RXi Pharmaceuticals Corp
04/26/2017 3 Dispersyn Gerrit (Chief Development Officer) has filed a Form 3 on RXi Pharmaceuticals Corp
01/17/2017 3 Eliseev Alexey (Chief Business Officer) has filed a Form 3 on RXi Pharmaceuticals Corp
04/22/2013 3 Lockshin Curtis (Director) has filed a Form 3 on RXi Pharmaceuticals Corp
04/22/2013 3 Dorman H. Paul (Director) has filed a Form 3 on RXi Pharmaceuticals Corp
03/19/2013 3 Advanced RNA Technologies, LLC (10% Owner) has filed a Form 3 on RXi Pharmaceuticals Corp
03/13/2013 3 Opko Health, Inc. (10% Owner) has filed a Form 3 on RXi Pharmaceuticals Corp
03/01/2013 3 Form 3 - Initial statement of beneficial ownership of securities
03/01/2013 3 CAUWENBERGH GEERT (President and CEO) has filed a Form 3 on RXi Pharmaceuticals Corp
03/01/2013 3 Pavco Pamela (Chief Development Officer) has filed a Form 3 on RXi Pharmaceuticals Corp
03/01/2013 3 Brownlie Keith L (Director) has filed a Form 3 on RXi Pharmaceuticals Corp
03/01/2013 3 Bitterman Robert J (Director) has filed a Form 3 on RXi Pharmaceuticals Corp

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy